Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer
ClinicalTrials.gov study NCT00436423. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1
ClinicalTrials.gov study NCT01524575. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer
ClinicalTrials.gov study NCT00020644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma
ClinicalTrials.gov study NCT03524898. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT04158635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
ClinicalTrials.gov study NCT03507491. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC
ClinicalTrials.gov study NCT01854203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01472770. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract
ClinicalTrials.gov study NCT00127595. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
ClinicalTrials.gov study NCT02267707. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer
ClinicalTrials.gov study NCT01409005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov study NCT01100372. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT06361030. IPD Sharing: YES. Countries: 1. Publications: 0.
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
ClinicalTrials.gov study NCT02428764. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT04338763. IPD Sharing: NO. Countries: 1. Publications: 0.
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
ClinicalTrials.gov study NCT00266097. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High
ClinicalTrials.gov study NCT06710288. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients
ClinicalTrials.gov study NCT03366272. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer
ClinicalTrials.gov study NCT01048320. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer
ClinicalTrials.gov study NCT00274859. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.